What Makes Elevance Health (ELV) an Investment Choice?

5 days ago 6

Soumya Eswaran

Mon, November 10, 2025 astatine 7:09 AM CST 3 min read

Pelican Bay Capital Management, an concern absorption company, released its third-quarter 2025 capitalist letter. A transcript of the aforesaid tin be downloaded here. PBCM Concentrated Value Strategy returned 7.8% successful the quarter, compared to a 5.3% instrumentality for the Russell 1000 Value Index. YTD, the money returned 11.2% compared to 11.6% for the index. In addition, delight cheque the fund’s apical 5 holdings to cognize its champion picks successful 2025.

In its third-quarter 2025 capitalist letter, PBCM Concentrated Value Strategy highlighted stocks specified arsenic Elevance Health, Inc. (NYSE:ELV). Elevance Health, Inc. (NYSE:ELV) is simply a wellness benefits company. The one-month instrumentality of Elevance Health, Inc. (NYSE:ELV) was -10.04%, and its shares mislaid 24.81% of their worth implicit the past 52 weeks. On November 7, 2025, Elevance Health, Inc. (NYSE:ELV) banal closed astatine $317.78 per share, with a marketplace capitalization of $70.623 billion.

PBCM Concentrated Value Strategy stated the pursuing regarding Elevance Health, Inc. (NYSE:ELV) successful its 3rd 4th 2025 capitalist letter:

"This 4th we besides initiated a caller presumption successful Elevance Health, Inc. (NYSE:ELV), a starring wellness security institution with implicit 45 cardinal members, operating done its well-known brands: Anthem Blue Cross Blue Shield for backstage employers and Wellpoint for Medicare and Medicaid plans. A cardinal competitory vantage is its in-house pharmacy payment manager (PBM), Carelon.

Elevance Health (ELV) Drops 18.66% After Dismal Q2 Earnings

Elevance Health, Inc. (NYSE:ELV) is not connected our database of 30 Most Popular Stocks Among Hedge Funds. As per our database, 67 hedge money portfolios held Elevance Health, Inc. (NYSE:ELV) astatine the extremity of the 2nd quarter, which was 75 successful the erstwhile quarter. In Q3 2025, Elevance Health, Inc. (NYSE:ELV) reported $50.1 cardinal of operating revenue, an summation of 12% year-over-year. While we admit the imaginable of Elevance Health, Inc. (NYSE:ELV) arsenic an investment, we judge definite AI stocks connection greater upside imaginable and transportation little downside risk. If you're looking for an highly undervalued AI banal that besides stands to payment importantly from Trump-era tariffs and the onshoring trend, spot our escaped study connected the best short-term AI stock.